Recurrent ventricular tachycardia in cardiac sarcoidosis: usefulness of fluorodeoxyglucose positron emission tomography for adequate management of corticoid therapy after placement of an implantable cardioverter defibrillator.
Casset-Senon
Danielle
D
Nuclear Medicine Department, Centre hospital-universitaire Trousseau, Tours, France. danielle.casset@gmail.com
Philippe
Laurent
L
Renard
Jean Paul
JP
Cosnay
Pierre
P
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D009202:Cardiomyopathies / Q000000981:diagnostic imaging* / Q000628:therapy*; D003131:Combined Modality Therapy; D004554:Electric Countershock; D019788:Fluorodeoxyglucose F18; D006801:Humans; D008297:Male; D008875:Middle Aged; D049268:Positron-Emission Tomography / Q000379:methods; D019275:Radiopharmaceuticals / Q000627:therapeutic use; D012507:Sarcoidosis / Q000000981:diagnostic imaging* / Q000628:therapy*; D055502:Secondary Prevention; D017180:Tachycardia, Ventricular / Q000000981:diagnostic imaging* / Q000628:therapy*
D000305:Adrenal Cortex Hormones; D000893:Anti-Inflammatory Agents; D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18